Live Quote · OTCREMIHealthcare· Medical - Instruments & Supplies

Remedent, Inc.

$0.00 0.00%(+$0.00)
TickerSpark Score
65/100
Solid
100
Valuation
40
Profitability
90
Growth
36
Health
60
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a REMI research report →

52-Week Range5% of range
Low
$0.00
Current
$0.00
High
$0.01
Company Overviewwww.remedent.com

About the company

Remedent, Inc. , operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers.

CEO
Guy De Vreese
IPO
2006
Employees
3
HQ
Gent, BE

Price Chart

-93.00% · this period
$0.01$0.01$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$14.00K
P/E
-0.05
P/S
0.01
P/B
0.01
EV/EBITDA
0.06
Div Yield
0.00%
Profitability
Gross Margin
61.17%
Op Margin
-12.46%
Net Margin
-27.83%
ROE
-11.26%
ROIC
-4.99%
Growth & Income
Revenue
$986.22K · 14.17%
Net Income
$-274,446 · 81.64%
EPS
$-0.01 · 81.68%
Op Income
$-122,890
FCF YoY
-145.91%
Performance & Tape
52W High
$0.01
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-0.43
Avg Volume
17.53K

Get TickerSpark's AI analysis on REMI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Dec 2, 15Sternberg Stuartbuy399,819
Dec 2, 15Sternberg Stuartbuy399,819
Jul 24, 13Sternberg Stuartother0
Jul 24, 13MARXE AUSTIN W & GREENHOUSE DAVID Msell2,848,408
Jul 18, 13MARXE AUSTIN W & GREENHOUSE DAVID Msell225,000
Jul 19, 13MARXE AUSTIN W & GREENHOUSE DAVID Msell165,000
Jul 19, 13MARXE AUSTIN W & GREENHOUSE DAVID Msell500
Jul 16, 13MARXE AUSTIN W & GREENHOUSE DAVID Msell713,025
Nov 30, 12MARXE AUSTIN W & GREENHOUSE DAVID Msell45,000
Dec 3, 12MARXE AUSTIN W & GREENHOUSE DAVID Msell200,000
Coverage · REMI

Our REMI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on REMI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate REMI report →
Internal Compare

Similar companies

Peers in the same neighborhood.